- Report
- June 2023
- 263 Pages
Global
From €3229EUR$3,600USD£2,847GBP
- Report
- June 2023
- 125 Pages
Asia Pacific
From €1345EUR$1,500USD£1,186GBP
- Report
- November 2025
Global
From €450EUR$537USD£411GBP
- Report
- January 2024
- 116 Pages
Global
From €4036EUR$4,500USD£3,558GBP
- Report
- July 2023
- 210 Pages
Global
From €4036EUR$4,500USD£3,558GBP
- Report
- September 2022
Global
€4990EUR$5,959USD£4,553GBP
- Report
- November 2020
- 450 Pages
Global
From €4395EUR$4,900USD£3,875GBP
- Report
- September 2020
- 700 Pages
Global
From €4395EUR$4,900USD£3,875GBP
- Report
- August 2019
- 42 Pages
Global
€2686EUR$2,995USD£2,368GBP
- Report
- March 2018
- 102 Pages
Global
From €2467EUR$2,750USD£2,175GBP
- Report
- October 2022
- 94 Pages
Global
From €1794EUR$2,000USD£1,582GBP
- Report
- January 2024
- 84 Pages
Global
From €3500EUR$4,180USD£3,194GBP
- Report
- January 2024
- 80 Pages
Global
From €3500EUR$4,180USD£3,194GBP
- Report
- October 2023
- 99 Pages
Global
From €3500EUR$4,180USD£3,194GBP
- Report
- October 2023
- 104 Pages
Global
From €3500EUR$4,180USD£3,194GBP
- Newsletter
- November 2025
- 12 Pages
China
From €179EUR$200USD£158GBP
- Report
- January 2025
- 132 Pages
Global
From €852EUR$950USD£751GBP

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer.
Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes.
Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more